Delisting risk
Apimeds Pharmaceuticals US
Developing a bee-venom knee-osteoarthritis therapy and Bitcoin-treasury infrastructure.
$3.87
After-hours close−0.01 (−0.26%)
At close$3.88(−1.77%)
| Date | Estimate | Reported | Surprise |
|---|---|---|---|
| Aug 2026 | — | −$11.77 | — |
| May 2026 | — | −$22.60 | — |
| Nov 2025 | — | −$0.14 | — |
| Aug 2025 | — | −$0.26 | — |
The latest year is open to everyone — the 1 quarter behind it read with an account. Sign in | |||
| May 2025 | |||
| Report date | EPS est | EPS | Surprise | Revenue est | Revenue | Surprise |
|---|---|---|---|---|---|---|
| Aug 14, 2026 | — | −$11.77 | — | — | — | — |
| May 26, 2026 | — | −$22.60 | — | — | — | — |
| Nov 12, 2025 | — | −$0.14 | — | — | — | — |
| Aug 19, 2025 | — | −$0.26 | — | — | — | — |
The latest year is open to everyone — the 1 quarter behind it read with an account. Sign in | ||||||
| May 19, 2025 | ||||||